Biospace.com

Is mRNA the Future of Drug Development

In short, mRNA therapies and vaccines are a way of turning the body into its own drug manufacturer. Even before the COVID-19 pandemic, Moderna was focused largely on infectious diseases and vaccines, with programs for influenza A, Chikungunya virus, Zika virus, Cytomegalovirus, human metapneumovirus (HMPV), parainfluenza virus (PIV3), and others.

Actived: 3 days ago

URL: biospace.com


Most Important Drugs Over the Past 10 Years BioSpace

(7 days ago) Looking back over the past year and even decade, STAT News takes a look back at the best drugs approved over the past 10 years in its weekly Readout podcast. The members of the STAT team argued over which drugs have had the greatest impact, such as newly-approved immunotherapy drugs in cancer.It started in 2011 with Bristol-Myers Squibb securing approval for Yervoy in 2011 but really …

Category:  Cancer Go Now


Veterinary Drugs Market: Increased medical and surgical

(3 days ago) The veterinary drugs market is prognosticated to observe considerable growth during the forecast period of 2016-2024. The animal ownership rate is increasing at a rapid pace. Furthermore, the livestock adoption rate is also growing exponentially. These factors will help in expanding the growth landscape of the veterinary drugs market during the forecast period.

Category:  Health Go Now


Top 10 Best-Selling Biotech Drugs BioSpace

(8 days ago) Biotech drugs differ from pharmaceutical drugs in that they use biotechnology as a means for manufacturing, which involves the manipulation of microorganisms, such as bacteria, or biological substances, like enzymes, to perform a specific process. These drugs can treat specific diseases and conditions, ranging from arthritis to cancer.

Category:  Pharmaceutical,  Cancer Go Now


Oncology Small Molecule Drugs Market: Key Trends

(7 days ago) Oncology Small Molecule Drugs Market: Overview. The oncology small molecule drugs market is prophesied to display phenomenal growth and outperform other available drug therapies for the treatment of cancer in the forthcoming years. The advent of small molecule drugs for cancer therapeutics is groundbreaking, transforming the entire cancer therapy landscape.

Category:  Cancer Go Now


Antiviral Drugs Market: Targeted Efforts towards Better

(9 days ago) The vendor landscape of the antiviral drugs market is consolidated with the dominated of few players, says Transparency Market Research (TMR). Some of the prominent players operating in the antiviral drugs market are F. Hoffmann-La Roche AG, Bristol-Myers-Squibb, Johnson & …

Category:  Health Go Now


Assisted Reproductive Technology Drugs Treatment Market

(7 days ago) The use of different classes of drugs in assisted reproduction has gained traction in recent years, due to a rise in prevalence of infertility. These drugs help at various phases of treatment in order to help with hormone regulation, triggered timed ovulation, and the prevention of ovarian hyperstimulation syndrome.

Category:  Health Go Now


6 Major Drug Recalls from the Past BioSpace

(6 days ago) Recalls for these drugs usually happen because of unexpected differences that change the outcome of use for patients. In other cases, new medication does go through extensive testing, research, development, and refinement. Recalls are still possible even after successful clinical trials. Zantac's recall, for instance, is happening because of an

Category:  Health Go Now


Anti-parasitic Drugs Market: Rising prevalence of

(3 days ago) Global Anti-parasitic Drugs Market: Snapshot. The anti-parasitic drugs refers to that very particular type of medications that are meant for the purpose of treatment of various parasitic diseases, such as those caused by parasitic fungi, protozoa, helminths, ectoparasites, and amoeba amongst many others.

Category:  Medications Go Now


Antidiabetic Herbal Drugs Market: Increase in incidence of

(1 days ago) The global antidiabetic herbal drugs market can be segmented based on application, therapy, distribution channel, and region. In terms of application, the market can be bifurcated into type 1 diabetes and type 2 diabetes. Based on therapy, the global antidiabetic herbal drugs market can be classified into botanical drugs and nutraceuticals.

Category:  Diabetes Go Now


Mental Disorders Drugs Market: Rising incidence of mental

(Just Now) The most common factor aiding the expansion of the global mental disorders drugs market is the rising incidence of mental disorders. For instance, as per the WHO’s reviewed fact sheet, as of 2016 over 350 million people worldwide are affected by depression, over 60 million people are diagnosed with bipolar disorder, and almost 21 million

Category:  Health Go Now


Benzodiazepine Drugs Market is Presumed to be Valued at US

(2 days ago) Anxiety was a dominant segment of the global benzodiazepine drugs market in 2017. It is expected to maintain its position during the forecast period. The segment is anticipated to reach a value of US$ 1,384.12 Mn by 2026. It is projected to account for 52.9% share of the market and expand at a CAGR of 3.1% during the forecast period.

Category:  Health Go Now


3D Printed Drug Market 3D Printed Drugs is Increasing

(8 days ago) Since 3D drugs can be customized as per the requirement of every patient, assisting way better than batch-produced drugs, their demand is predicted to increase substantially in the years to come. Overall, the future of the worldwide market for 3D printed drugs looks bright.

Category:  Health Go Now


Anesthesia Drugs Market Latest Study How has COVID-19

(8 days ago) The global anesthesia drugs market is expected to chart a high growth trajectory in the forecast period of 2019 to 2029. Surge in number of various types of surgeries is one of the key reasons for this remarkable growth. Anesthesia is a one of most important steps performed before starting any surgery.

Category:  Health Go Now


Top 10 Most Expensive Drugs on the Market BioSpace

(9 days ago) Other drugs included in this year’s top 10 list should come as no surprise. Familiar drug names including Myalept, Folotyn, Soliris and other drugs remain on the GoodRx list. Other drugs, including Lumizyme ($630,630), Actimmune ($575,540) and Takhzyro ($573,820) were knocked off this year’s list due to higher-priced drugs.

Category:  Health Go Now


Merck’s Anti-Cholesterol Drug Threatens Esperion, Other

(5 days ago) All of the drugs in this category may be facing a challenge if Merck can bring the drug to the finishing line, which is still only in Phase I trials. But in the study, Merck’s drug decreases LDL cholesterol by about 65%. Nexletol alone lowers cholesterol by 15–25%, and …

Category:  Health Go Now


Targeted Therapy Drugs will Account for 50% of Oncology

(1 days ago) High prevalence of cancer, coupled with the increasing demand for targeted therapy drugs will drive oncology small molecule drugs sales. Fact.MR, New York: Fact.MR’s recent study has projected the global oncology small molecule drugs market to grow at a healthy pace through 2021. Rising prevalence of cancer and improving availability of oral small molecule drugs for cancer …

Category:  Health,  Cancer Go Now


The FDA Approves Drugs Faster, But That Might Not Be A

(8 days ago) The FDA Approves Drugs Faster, But That Might Not Be A Good Thing. In a second research report published this year so far, investigators found that the U.S. Food and Drug Administration (FDA) is approving drugs faster than ever. Unfortunately, it appears that the agency is also approving those drugs on less data and weaker evidence. The first

Category:  Health Go Now


Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs

(2 days ago) The global Methicillin-resistant Staphylococcus Aureus Drugs Market was valued at approximately US$ 2.9 Bn in 2016 is projected to register cumulative annual growth rate of over 3.2% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Methicillin-resistant Staphylococcus Aureus Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends

Category:  Health Go Now


Gastrointestinal Drugs Market: High Prevalence of GI

(4 days ago) A report by Transparency Market Research states that the global gastrointestinal drugs market is expected to witness a robust growth during the tenure of 2016 to 2024. According to the report, the growth of the market is the result of increasing number of patients suffering from stomach and intestine infections in past few years.

Category:  Health Go Now

Top Categories

Popular Searched

 › Zip codes with medicare give back benefits

 › Drugs for lung disease

 › Drugs that caused birth defects

 › Medicare benefits by zip code

 › Us sentencing guidelines drug calculator

 › Abc the good doctor watch full episodes

 › Pharmacy tech training in ohio

 › Peabody family health center

 › Hospitals in palm bay florida

 › Tampa florida medical school

 › Aarp medicare supplement vision dental

 › Maryland primary care annapolis

 › Shoppers drug mart pfizer

 › Nevada medicaid find a doctor

 › Methodist medical supply peoria il

Recently Searched

 › Medical examiner office jobs

 › Disadvantages of paper medical records

 › How to read a drug screen

 › Medical student loan forgiveness program

 › Bartell drugs university place wa

 › Medical contract management software

 › Forsyth medical center novant health record

 › Medicaid home health care providers

 › Afc urgent care locations ma

 › Dallas city medical center

 › Fun facts about doctors

 › Where to eat healthy near me

 › United health system ny

 › Goshen medical center fayetteville nc

 › Philadelphia va medical center directory